Literature DB >> 11090188

Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

M Mach1, B Kropff, P Dal Monte, W Britt.   

Abstract

The envelope glycoproteins of human cytomegalovirus (HCMV) virions are incompletely characterized. We have analyzed complex formation between glycoprotein M (gM or gpUL100) and a second glycoprotein. gM-homologous proteins are conserved throughout the herpesvirus family and represent type III membrane proteins containing multiple hydrophobic sequences. In extracellular HCMV particles, gM was found to be complexed through disulfide bonds to a second protein with an apparent molecular mass of 50 to 60 kDa. The 50- to 60-kDa protein was found to be derived from reading frame UL73 of HCMV strain AD169. UL73-homologous genes are also conserved within herpesviruses. When transiently expressed by itself, the UL73 gene product consisted of a protein of 18 kDa. However, in the presence of gM, the UL73 gene product was posttranslationally modified to the 50- to 60-kDa species. Thus, gM and the UL73 gene product, which represents the gN homolog of herpesviruses, form a disulfide-linked complex in HCMV virions. Transient expression of gM and gN followed by fluorescence imaging with monoclonal antibodies against either protein demonstrated that complex formation was required for transport of the proteins from the endoplasmic reticulum to the Golgi and trans-Golgi compartments. Finally, we tested the gM-gN complex for reactivity with sera from HCMV-seropositive donors. Whereas most sera failed to react with either gM or gN when expressed alone, 62% of sera were positive for the gM-gN complex. Because a murine monoclonal antibody reactive with gN in the gM-gN complex efficiently neutralizes infectious virus, the gM-gN complex may represent a major antigenic target of antiviral antibody responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090188      PMCID: PMC112471          DOI: 10.1128/jvi.74.24.11881-11892.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

Authors:  W J Britt; L G Vugler
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Cleavage and purification of prokaryotically expressed HIV gag and env fusion proteins for detection of HIV antibodies in the ELISA.

Authors:  S Ellinger; M Mach; K Korn; G Jahn
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

3.  The UL10 gene of herpes simplex virus 1 encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells.

Authors:  J D Baines; B Roizman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Characterization of the UL10 gene product of herpes simplex virus type 1 and investigation of its role in vivo.

Authors:  C A MacLean; L M Robertson; F E Jamieson
Journal:  J Gen Virol       Date:  1993-06       Impact factor: 3.891

5.  Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus.

Authors:  M T Huber; T Compton
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Analysis of human antibody responses to human cytomegalovirus envelope glycoproteins found in two families of disulfide linked glycoprotein complexes designated gC-I and gC-II.

Authors:  B Kari; R Gehrz
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II.

Authors:  B Kari; R Gehrz
Journal:  J Gen Virol       Date:  1993-02       Impact factor: 3.891

8.  Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.

Authors:  G S Marshall; G P Rabalais; G G Stout; S L Waldeyer
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

9.  A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope.

Authors:  B Kari; R Gehrz
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Processing of human cytomegalovirus envelope glycoproteins in and egress of cytomegalovirus from human astrocytoma cells.

Authors:  B Kari; R Radeke; R Gehrz
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

View more
  55 in total

1.  Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.

Authors:  Regan N Theiler; Teresa Compton
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 2.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

3.  Analysis of the requirement for glycoprotein m in herpes simplex virus type 1 morphogenesis.

Authors:  Helena Browne; Susanne Bell; Tony Minson
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

Authors:  Zhongde Wang; Corinna La Rosa; Zhongqi Li; Heang Ly; Aparna Krishnan; Joy Martinez; William J Britt; Don J Diamond
Journal:  Vaccine       Date:  2006-10-06       Impact factor: 3.641

5.  Glycoprotein M of herpes simplex virus 1 is incorporated into virions during budding at the inner nuclear membrane.

Authors:  Joel D Baines; Elizabeth Wills; Robert J Jacob; Janice Pennington; Bernard Roizman
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.

Authors:  Michael Mach; Karolina Osinski; Barbara Kropff; Ursula Schloetzer-Schrehardt; Magdalena Krzyzaniak; William Britt
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 7.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

8.  Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M.

Authors:  Andrea D Lipińska; Danijela Koppers-Lalic; Michał Rychłowski; Pieter Admiraal; Frans A M Rijsewijk; Krystyna Bieńkowska-Szewczyk; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09

10.  Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge.

Authors:  Huadong Wang; Yanfeng Yao; Chaoyang Huang; Quanjiao Chen; Jianjun Chen; Ze Chen
Journal:  Virol Sin       Date:  2013-05-24       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.